Zepp Health (NYSE:ZEPP) Cut to Sell at Wall Street Zen

Wall Street Zen cut shares of Zepp Health (NYSE:ZEPP) from a hold rating to a sell rating in a research report sent to investors on Sunday.

Separately, Fundamental Research set a $53.01 target price on Zepp Health and gave the company a “buy” rating in a report on Tuesday, August 11th. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $53.01.

Zepp Health Stock Up 2.8%

ZEPP opened at $5.13 on Friday. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.88 and a quick ratio of 0.67. The business has a 50 day simple moving average of $5.05 and a 200-day simple moving average of $11.11. The stock has a market capitalization of $75.31 million, a P/E ratio of -2.04 and a beta of 1.86. Zepp Health has a 12 month low of $3.85 and a 12 month high of $61.85.

Insider Buying and Selling at Zepp Health

In related news, CFO Cheng Deng sold 9,836 shares of Zepp Health stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $4.61, for a total transaction of $45,343.96. Following the completion of the transaction, the chief financial officer directly owned 114,539 shares in the company, valued at $528,024.79. The trade was a 7.91% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 36.00% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Zepp Health

A number of large investors have recently bought and sold shares of the stock. Monolith Management Ltd acquired a new stake in shares of Zepp Health during the fourth quarter valued at $3,601,000. Harvest Fund Management Co. Ltd lifted its stake in shares of Zepp Health by 6.7% during the 4th quarter. Harvest Fund Management Co. Ltd now owns 44,800 shares of the company’s stock worth $1,207,000 after purchasing an additional 2,800 shares during the period. Themes Management Co LLC acquired a new stake in shares of Zepp Health during the fourth quarter worth $489,000. Capstone Capital Management Ltd acquired a new stake in shares of Zepp Health during the fourth quarter worth $298,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Zepp Health in the fourth quarter valued at $543,000. Institutional investors and hedge funds own 52.61% of the company’s stock.

About Zepp Health

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.